Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hi. In what year will AXXA hit $5?
Excellent SBFM 2022 Annual Report and Recent Highlights.....looking forward to 2023 and beyond!
Full Year 2022 and Recent Highlights:
-- Listing on NASDAQ.
-- Bolstered balance sheet with cash and cash and cash equivalents of $21
million.
-- Acquisition of Nora Pharma Inc. in October 2022, giving the Company 49
prescription drugs on the market in Canada.
-- Expansion of proprietary drug development program including the signing
of agreements with the University of Arizona for SBFM-PL4 COVID-19
treatment and the Jewish General Hospital (Montreal, Canada) for
IND-enabling studies of Adva-27a anticancer compound.
-- Advancing the development of the Company's anticancer K1.1 mRNA program
by entering into collaboration and testing agreement with one of the
leading lipid nanoparticle formulation companies in North America.
-- Increased sales from $228,426 in 2021 to $4,345,603 in 2022, largely due
to inclusion of the 72 days of Nora Pharma operations, the time since the
closing of the acquisition.
I see that CCAJ also addressed the lack of communication on Twitter on March 31, 2023 and referred everyone to their website for updates. I don't see anything about the properties there yet, so hopefully soon.
CCAJ Twitter: https://twitter.com/ccajstock/with_replies
CCAJ Website: https://coastalcapitalacquisitioncorp.com/investor-relations/
$.07, $.35, $.75, $1.00 all sound good....let's see where 2023 lands.
"ResearchThis" predicts $1.00 and my Crystal Ball says somewhere between $.10-1.00
I'm listening to my Crystal Ball which tells me 2023 is the turnaround year. Let's see where AXXA lands by December 31, 2023....at either $.001 or $1.00 or somewhere in between!
Give it 6-9 more months. After all these years that shouldn't be too much to ask. By then we should know for sure about that status of the Covid treatment and the cancer treatment (both are supposed to start additional trials this year). By then, you'll also know for sure about delisting (or not delisting)!
That is my timeline and if things are improving I'll stick around another year or so.
The CCAJ asset numbers look good with substantial increase year over year:
Total Assets: $ 16,256,853 (as of 12/31/22)
$ 2,562,120 (as of 12/31/21)
Thanks for the SEC update keeping CCAJ honest.
Yes, and if I recall correctly CCAJ had some property identified to build on. It would be good to see the foundations!
Anywhere between $.10-1.00 works for my piece of the pie!
CCAJ filed Annual Report today. Nothing new so seems like they aren't doing much, but will stay Pink Current. Let us know if anything comes from the SEC.
Why did SBFM go up 7% afterhours? This is not typical.
I'll be content with a return to $.10 this year. $.10+ is gravy for me.
New CCAJ/CCAC Website: https://coastalcapitalacquisitioncorp.com/
Thanks, except for the new website they have been silent about any activity since December. Prior to that they were also silent from June-December so it seems as though they are either doing things they can't announce yet or they aren't doing anything except creating a new website.
What is the window of time you are referring too before shareholders can make "millions?" Is it 1 year, 2 years, 5 years? I'm curious how much patience you have?
I've got some cash lined up if the dumpsters are done and the Annual Report has anything good in it!
Will we see the CCAJ Annual Report on March 30, 2023?
Are the CCAJ dumpsters done yet?
SBFM progress pipeline (October 2022-February 2023):
1. PLpro-based COVID Treatment (signed agreement with UoA in February 2023)
2. Adva-27a Cancer Treatment (signed agreement with Jewish General Hospital/McGill U in February 2023)
3. Share Repurchase Program (authorized in January 2023)
4. K1.1 mRNA-based LNP Cancer Treatment (entered collaboration agreement with a leading LNP company in November 2022)
5. Growing Nora Pharma, Inc. (acquired in October 2022)
I'm here until December 31, 2023 or $.25, whichever comes first! To whoever controls the PPS, let it be $.25
Well, it is time for SBFM to move back to the $10-20 range in 2023 and higher in 2024 and perhaps higher in 2025!
Don't forget they are progressing on:
1. PLpro-based COVID Treatment
2. Adva-27a Cancer Treatment
3. K1.1 mRNA-based LNP Cancer Treatment
And they acquired Nora Pharma, Inc. and announced a Share Repurchase program within the past 3-6 months.
By multi-year I meant 2023-2025. SBFM may go up from here beginning any day, week or month from now and gradually increase to the multi-dollars range.
From the recent NEWS, looks like SBFM will be a multi-year potential money-making stock from these lows. Not sure when it will go up next, but they have definitely lined up the clinical research pathway for both Cancer (McGill U) and Covid (UoA). As they progress I do believe dollars per share are on the horizon.
I am planning to buy a few more shares in the coming days, and good luck to those who stick around and those who don't.
Thanks. I guess we'll get the answer in writing from CCAJ at some point.
Let's see your simple math on when the PPS will rise from the ashes........
What + What = a much higher PPS
Thanks. Your explanation was quite informative.
Sounds like it might work, but we'll see. I'm planning to hold on in 2023, but the past year and a half was a long downward path in terms of the PPS.
If AXXA is doing all the right things then why did the PPS go from over $.08 in late 2021 to $.0068 now? Or, did they not do the right things to protect shareholder value? Please explain.
No, I'm saying AXXA should use funds to buy from the open market and then take the shares out of circulation. That would make the PPS rise so they likely wouldn't get amount of shares I estimated. Nonetheless, the impact on the PPS would likely generate more new investor enthusiasm than what they have been doing. Just a common sense thought based on supply and demand! Currently there is too much supply of shares and not enough demand to push the price higher. That is what AXXA needs to fix and I don't see a plan for that.
AXXA should have used the $1.5M on a share buyback instead of the memorabilia! They could have bought back almost 215,000,000 shares at today's price. NEWS about that probably would have had a much greater positive effect than the memorabilia NEWS they put out!
Excellent COVID Update: Tech Launch Arizona, the office of UArizona that commercializes inventions stemming from research, has been working with pharmaceutical company Sunshine Biopharma Inc. (NASDAQ: “SBFM”) to develop pathways to bring the invention to the public. The license grants Sunshine Biopharma worldwide rights for the University of Arizona and University of Illinois Chicago patent rights pertaining to PLpro protease inhibitors of SARS-CoV-2 developed by the researchers.
Let's get it back to $10/PPS first!
Excellent update on SBFM COVID treatment progress. Looks like Greg Thatcher and colleagues are planning to take this all the way to the FDA!
PS: I know a couple people who recently needed COVID treatment so looks like there is and will be a market for some time to come in the US and beyond.
No way $1.00 unless AXXA buys back 75% of the float. Even then not sure it could make it past $.40.
How do you see $1.00?
I was thinking the company (CCAJ) should cancel the proposed RS and buy back something like 500 million shares (about $750,000 at today's market prices) over the next several weeks and then use those shares for the merger/acquisitions. I think CCAJ has some money to do this!
I'm sure the price would go up if they were to do this so they wouldn't get 500 million for $750,000 and would have to put out more cash for that amount of shares.
I know this is a pipedream, but that was my thinking on the current situation.
Looks like they updated to a new website recently, but have the same info.
This new site looks better, but not sure if this new site means much in terms of what is happening behind the scenes. https://coastalcapitalacquisitioncorp.com/acquisitions/
The old one is still there (as of today at least):
https://coastalcapitalac.com/acquisitions
It is on the CCAJ website as an "Identified Acquisition." See link:
https://coastalcapitalac.com/acquisitions
More details please....who owns it if AXXA don't?
CCAJ should cancel the RS and buyback half the float! That should make the price go up significantly. I remember when some thought CCAJ would hit $0.20!
A 1:10 RS at .20 makes a lot more sense to get up to $2.00.